Home > Archive>Volume 10, Issue 11, 2017 >1669-1677. DOI:10.18240/ijo.2017.11.06
PDF HTML XML Export Cite reminder
Effect of mistletoe combined with carboxymethyl cellulose on dry eye in postmenopausal women
Author:
Corresponding Author:

Yi Shao. Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang 330006, Jiangxi Province, China. freebee99@163.com

Fund Project:

Supported by the National Natural Science Foundation of China (No.81460092, No.81660158 and No.81400372); Natural Science Key Project of Jiangxi Province (No.20161ACB21017); Youth Science Foundation of Jiangxi Province (No.20151BAB215016); Technology and Science Foundation of Jiangxi Province (No.20151BBG70223)

  • Article
    • | |
  • Metrics
    • |
  • Reference [51]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    AIM: To investigate the protective effect of mistletoe combined with carboxymethyl cellulose eye drops on dry eye in postmenopausal women. METHODS: Sixty postmenopause female patients diagnosed of dry eye were assigned randomly to mistletoe combined with carboxymethyl cellulose eye drops treatment group (n=30) and control group treated with normal saline eye drops (n=30). The subjective symptoms of ocular surface, Ocular Surface Disease Index (OSDI), tear film function tests, tear protein and corneal morphology by confocal scanning microscopy were analyzed before treatment and at 1, 2, 4 and 8wk after treatment respectively. To ensure the safety of the trial, all patients were examined with systolic pressure, diastolic pressure, glutamic-pyruvic transaminase, glutamic oxaloacetic transaminase, urine creatinine, and blood urea nitrogen at 8wk after treatment. RESULTS: There were no obvious differences between two groups before the treatment (P>0.05). In two months after the treatment, the symptoms of ocular surface, OSDI, tear protein, and tear film function were only slightly changed in normal saline eye drops group. However, all indices were improved after the treatment of mistletoe combined with carboxymethyl cellulose eye drops group (P<0.05). In addition, the average amount of corneal epithelium basal cells and inflammatory cells of mistletoe treated group were 3174±379 and 38±25 cells/mm2, significantly decreased as compared to the control group with 4309±612 and 158± 61 cells/mm2, respectively. In the control group, although nerves still maintained straight under corneal epithelium, the number of nerves were significantly decreased, as compared with normal female. In the mistletoe treated group, the number of nerves was only slightly reduced, compared with normal female. CONCLUSION: Mistletoe combined with carboxymethyl cellulose eye drops can alleviate the symptoms and signs of dry eye symptoms.

    Reference
    1 Sahai A, Malik P. Dry eye: prevalence and attributable risk factors in a hospital-based population. Indian J Ophthalmol 2005;53(2):87-91.
    2 Gipson IK, Spurr-Michaud SJ, Senchyna M, Ritter R 3rd, Schaumberg D. Comparison of mucin levels at the ocular surface of postmenopausal women with and without a history of dry eye. Cornea 2011;30(12):1346-1352.
    3 Azcarate PM, Venincasa VD, Feuer W, Stanczyk F, Schally AV, Galor A. Androgen deficiency and dry eye syndrome in the aging male. Invest Ophthalmol Vis Sci 2014;55(8):5046-5053.
    4 Miljanovi? B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007; 143(3):409-415.
    5 Liu Z, Pflugfelder SC. Corneal thickness is reduced in dry eye. Cornea 1999;18(4):403-407.
    6 Lobo R, Sodde V, Dashora N, Gupta N, Prabhu K. Quantification of flavonoid and phenol content from Macrosolen parasiticus (L.) Danser. Nat Prod Plant Resour 2011;1(4):96-99.
    7 Ofem OE, Antai AB, Essien NM, Oka VO. Enhancement of some sex hormones concentrations by consumption of leaves extract of Viscum album (mistletoe) in rats. Asian Journal of Medical Sciences 2014;5(3): 14-16.
    8 Korman DB. Mistletoe lectins-antitumor effect and mechanism of action. Vopr Onkol 2011;57(6):689-698.
    9 Eisenbraun J, Scheer R, Kröz M, Schad F, Huber R. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract. Phytomedicine 2011;18(2-3):151-157.
    10 Abdel-Sattar E, Harraz FM, Ghareib SA, Elberry AA, Gabr S, Suliaman MI. Antihyperglycaemic and hypolipidaemic effects of the methanolic extract of Caralluma tuberculata in streptozotocin-induced diabetic rats. Nat Prod Res 2011;25(12):1171-1179.
    11 Braun JM, Ko HL, Schierholz JM, Weir D, Blackwell CC, Beuth J. Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models. Cancer Lett 2001;170(1):25-31.
    12 Munteanu MF, Ardelean A, Borcan F, Trifunschi SI, Gligor R, Ardelean SA, Coricovac D, Pinzaru I, Andrica F, Borcan LC. Mistletoe and garlic extracts as polyurethane carriers - a possible remedy for choroidal melanoma. Curr Drug Deliv 2017:14(999).
    13 Zhang X, Zhao L, Deng S, Sun X, Wang N. Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics. J Ophthalmol 2016;2016(2):1-7.
    14 Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118(5):615-621.
    15 Walt JG, Ravelo AL, Lee JT, Lee L. Assessing the functional impact and severity of ocular surface disease using the Ocular Surface Disease Index (OSDI©). The Ocular Surface 2005;3(12):S124-S124.
    16 Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, Asbell PA, Pflugfelder SC. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 2010;128(1):94-101.
    17 de Souza GA, Godoy Lyri MF, Matthias M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome biology 2006;7(8):R72.
    18 Sakane Y, Yamaguchi M, Yokoi N, Uchino M, Dogru M, Oishi T, Ohashi Y, Ohashi Y. Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire. JAMA Ophthalmol 2013;131(10): 1331-1338.
    19 Srinivasan S, Joyce E, Boone A, Simpson T, Jones L, Senchyna M. Tear lipocalin and lysozyme concentrations in postmenopausal women. Ophthalmic Physiol Opt 2010;30(3):257-266.
    20 Chen W, Li Z, Hu J, Zhang Z, Chen L, Chen Y, Liu Z. Corneal alternations induced by topical application of benzalkonium chloride in rabbit. PLoS One 2011;6(10):e26103.
    21 Galor A, Levitt RC, Felix ER, Martin ER, Sarantopoulos CD. Neuropathic ocular pain: an important yet underevaluated feature of dry eye. Eye (Lond) 2015;29(3):301-312.
    22 Bakkar MM, Shihadeh WA, Haddad MF, Khader YS. Epidemiology of symptoms of dry eye disease (DED) in Jordan: A cross-sectional non-clinical population-based study. Cont Lens Anterior Eye 2016;39(3):197-202.
    23 Osae AE, Gehlsen U, Horstmann J, Siebelmann S, Stern ME, Kumah DB, Steven P. Epidemiology of dry eye disease in Africa: the sparse information, gaps and opportunities. Ocul Surf 2017;15(2):159-168.
    24 Jin KW, Ro JW, Shin YJ, Hyon JY, Wee WR, Park SG. Correlation of vitamin D levels with tear film stability and secretion in patients with dry eye syndrome. Acta Ophthalmol 2017;95(3):e230-e235.
    25 The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop (2007). Ocul Surf 2007;5(2):75-92.
    26 Alves M, Fonseca EC, Alves MF, Malki LT, Arruda GV, Reinach PS, Rocha EM. Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. The Ocular Surface 2013;11(3):181-192.
    27 Geerling G, Sieg P, Bastian GO, Laqua H. Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca. Ophthalmology 1998;105(2):327-335.
    28 Dutescu RM, Panfil C, Schrage N. Comparison of the effects of various lubricant eye drops on the in vitro rabbit corneal healing and toxicity. Exp Toxicol Pathol 2017;69(3):123-129.
    29 Beckman KA, Luchs J, Milner MS, Ambrus JL Jr. The potential role for early biomarker testing as part of a modern, multidisciplinary approach to sjögren's syndrome diagnosis. Adv Ther 2017;34(4):799-812.
    30 Molina-Leyva I, Molina-Leyva A, Bueno-Cavanillas A. Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials. Acta Ophthalmologica 2017.
    31 Kandel H, Khadka J, Goggin M, Pesudovs K. A pair of glasses and beyond: impact of refractive error on people’s well-being. Clin Exp Ophthalmol 2017;45(7):677-688.
    32 Vehof J, Hysi PG, Hammond CJ. A metabolome-wide study of dry eye disease reveals serum androgens as biomarkers. Ophthalmology 2017;124(4):505-511.
    33 Handelsman DJ. Androgen misuse and abuse. Best Pract Res Clin Endocrinol Metab 2011;25(2):377-389.
    34 Azzarolo AM, Wood RL, Mircheff AK, Richters A, Olsen E, Berkowitz M, Bachmann M, Huang ZM, Zolfagari R, Warren DW. Androgen influence on lacrimal gland apoptosis, necrosis, and lymphocytic infiltration. Invest Ophthalmol Vis Sci 1999;40(3):592-602.
    35 Rocha EM, Wickham LA, da Silveira LA, Krenzer KL, Yu FS, Toda I, Sullivan BD, Sullivan DA. Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol 2000;84(1):76-84.
    36 Yu J, Zheng XL, Li YY, Hu PH, Liu RQ, Jiang N, Pei CG, Shao Y. Clinical findings associated with Bidens bipinnata L. eye drops on moderate and severe dry eye in postmenopausal women. Int J Clin Exp Med 2016;9(3):5643-5654.
    37 Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000;78(2):146-153.
    38 Shao Y, Yu Y, Yu J, Pei CG, Gao GP, Tu P. Experimental study on efficiency of Spanishneedles Herb eye drops in treating perimenopausal xerophthalmia in rabbits. Zhongguo zhongyao zazhi 2015;40(6): 1151-1155.
    39 Shao Y, Yu Y, Huang GD, Tan G, Pei CG, Liu XH. Clinical study on spanishneedles leaves in treatment of middle and severe xerophthalmia of menopausal females. Zhongguo zhongyao zazhi 2012;37(19):2985-2989.
    40 Al-Gayyar MM, Ebrahim MA, Shams ME. Measuring serum levels of glycosaminoglycans for prediction and using viscum fraxini-2 for treatment of patients with hepatocellular carcinoma. Journal of Pharmacy Research 2013;7(7):571-575.
    41 Werthmann PG, Sträter G, Friesland H, Kienle GS. Durable response of cutaneous squamous cell carcinoma following high-dose peri-lesional injections of Viscum album extracts-a case report. Phytomedicine 2013;20(3-4):324-327.
    42 Tröger W, Galun D, Reif M, Schumann A, Stankovi? N, Mili?evi? M. Viscum album[L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer 2013;49(18):3788-3797.
    43 Agrawal M, Nandini D, Sharma V, Chauhan NS. Herbal remedies for treatment of hypertension. Int J Pharm Sci and Res 2010;1(5):1-21.
    44 Rysz J, Franczyk B, Banach M, Gluba-Brzozka A. Hypertension- current natural strategies to lower blood pressure. Curr Pharm Des 2017;23(17):2453-2461.
    45 Glickman-Simon R, Pettit J. Viscum album (mistletoe) for pancreatic cancer, electromagnetic field therapy for osteoarthritis, homeopathy for multidrug-resistant tuberculosis, vitamin D for depression, acupuncture for insomnia. Explore (NY) 2015;11(3):231-235.
    46 Fuchsjäger-Mayrl G, Nepp J, Schneeberger C, Sator M, Dietrich W, Wedrich A, Huber J, Tschugguel W. Identification of estrogen and progesterone receptor mRNA expression in the conjunctiva of premenopausal women. Invest Ophthalmol Vis Sci 2002;43(9):2841-2844.
    47 Yu Y, Cai W, Pei CG, Shao Y. Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy. Biochem Biophys Res Commun 2015;458(4):913-919.
    48 Deeni YY, Sadiq NM. Antimicrobial properties and phytochemical constituents of the leaves of African mistletoe (Tapinanthus dodoneifolius (DC) Danser) (Loranthaceae): an ethnomedicinal plant of Hausaland, Northern Nigeria. J Ethnopharmacol 2002;83(3):235-240.
    49 Ye LH, Ye L, Tang LY, Jiang N, Gao GP, Shao Y. Experimental study on efficiency of mistletoe eye drops in treating xerophthalmia of castrated male rabbits. Rec Adv Ophthalmol 2016;36(10):915-918,922.
    50 Ye L, Ye LH, Zhang Y, Wei R, Jiang N, Pei CG, Gao GP, Shao Y. Experimental study on mistletoe eye drops in prevention of xerophthalmia of castrated male rabbits. China Journal of Modern Medicine 2017;27(7): 20-24.
    51 Wang GL, Ye LH, Ye L, Yang QC, Jiang N, Shao Y. Effects of mistletoe eye drops in treating xerophthalmia of perimenopausal female rabbits. Chin Hosp Pharm J 2017;37(9):830-833.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Nan Jiang, Lin-Hong Ye, Lei Ye,/et al.Effect of mistletoe combined with carboxymethyl cellulose on dry eye in postmenopausal women. Int J Ophthalmol, 2017,10(11):1669-1677

Copy
Share
Article Metrics
Article has an altmetric score of 1
Article has an altmetric score of 1
  • Abstract:2165
  • PDF: 904
  • HTML: 333
  • Cited by: 0
Publication History
  • Received:October 25,2016
  • Revised:June 13,2017
  • Online: November 07,2017
You are the 4405391 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
International Journal of Ophthalmology ® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.